Making Cents Sense

Why I Love Stocks Everyone Else Hates One of the strangest things I've learned as an investor is that the stock market often rewards people for buying things nobody wants. That sounds backward because it is backward. Most of life teaches us to follow popularity. Popular restaurants are usually good. Popular movies are usually entertaining. Popular products often become popular for a reason. Stocks operate under a different set of rules. By the time everybody loves a stock, the good news is often already reflected in the price. Meanwhile, the companies buried beneath bad headlines, analyst downgrades, angry social media posts, and massive short interest can sometimes become the most interesting opportunities in the market. That's why I've become fascinated with what I call "Shorted but Strong." These are companies that Wall Street hates, traders are betting against, and financial media treats like cautionary tales—yet the underlying business remains surpris...

For most of my investing life, I believed the market rewarded courage. The loudest voices on financial television certainly seemed convinced of it. Every day there was a new revolutionary technology, a new hyper-growth stock, a new industry supposedly destined to change civilization forever. The message was always the same: if I wanted exceptional returns, I had to chase exceptional stories. And for a while, that idea made perfect sense. After all, growth is exciting. Income is boring. Nobody gathers around the water cooler to discuss a utility company raising its dividend by 4%. Nobody posts screenshots of a stable infrastructure fund generating predictable cash flow. Nobody brags at parties about owning a pipeline operator that quietly distributes income every quarter. Instead, people talk about the stock that doubled. The startup that exploded higher. The company that turned a thousand dollars into ten thousand. The financial media loves excitement because excitement generates atten...

For most investors, the stock market is a popularity contest. For me, it's a scavenger hunt. I'm not looking for the stocks everyone already loves. By the time financial television is discussing them nonstop and social media has turned them into cults, the easy money is often gone. The crowd has arrived. The narrative has formed. The expectations are sky-high. I'm looking for something different. I'm looking for catalysts. Specifically, I'm looking for moments when reality is changing faster than Wall Street's perception of reality. That's where pharmaceutical stocks become fascinating. Not because they're easy. Not because they're predictable. And certainly not because they don't occasionally resemble a casino run by molecular biologists. They're fascinating because few sectors create larger disconnects between present value and future value. A biotech company can look worthless today and become enormously valuable tomorrow. Like...

Why Money Never Sits Still, Why Investors Chase Yesterday’s Winners, and Why the Biggest Opportunities Often Appear When Nobody Wants Them If there's one lesson the market keeps teaching me, it's this: Money is restless. It never sits still. It never falls in love. It never stays loyal. It never cares about the story investors tell themselves. Capital is constantly searching for its next destination, moving from fear to optimism, from caution to speculation, from safety to innovation, and then right back again. Watching this happen is like watching human psychology perform interpretive dance while wearing a suit. Everyone thinks they're making rational decisions. Meanwhile, trillions of dollars are stampeding from one corner of the market to another because somebody used the phrase "AI opportunity" on an earnings call. The longer I invest, the more I realize that understanding capital rotation is often more important than understanding individual compan...